Relapse recovery: The forgotten variable in multiple sclerosis clinical trials
Conclusions
In patients with MS presenting without good recovery after the initial relapse, immediate DMT initiation favorably influences the likelihood of more ambulatory-benign disease akin to patients with good recovery after the initial relapse.
Classification of evidence
This study provides Class III evidence that for patients with MS without good recovery after the initial relapse, immediate DMT initiation increases the likelihood of a benign disease course.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Kantarci, O. H., Zeydan, B., Atkinson, E. J., Conway, B. L., Castrillo-Viguera, C., Rodriguez, M. Tags: Quality of life, Class III, Burden of disease, Multiple sclerosis Article Source Type: research
More News: Avonex | Brain | Clinical Trials | Disability | Multiple Sclerosis | Neurology | Rebif | Statistics | Study